Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical cidofovir for perianal HSIL in HIV-infected patients
NCT00550589Phase 2Completed
- Sponsor
- AIDS Malignancy Consortium
- Start
- Sep 2007
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cidofovir in Squamous Intraepithelial Lesion (SIL), sponsored by AIDS Malignancy Consortium. Started Sep 2007; status: completed.
02
Drugs
cidofovir
03
Conditions
Squamous Intraepithelial Lesion (SIL)
Beyond the preview
Go deeper on NCT00550589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550589.